Malignant Atrophic Papulosis: Clinical Trials

1 trial for Malignant Atrophic Papulosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Malignant Atrophic Papulosis: new trials by email Literature Review of Malignant Atrophic Papulosis trials Research Report on Malignant Atrophic Papulosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
JAK/STAT Inhibition in CNS Kohlmeier-Degos Disease
Ruxolitinib - Kohlmeier Degos Disease With Neurologic Involvement, Kohlmeier-Degos Disease
Phase 1 / Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)12023-09-282026-02-03

Broader conditions

Arterial Occlusive Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Interventions

ruxolitinib (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (1)

Countries

United States (1)

Top investigators

Cornelia D Cudrici, M.D. (1)

Results publications

PMID 42532045